Winamp Logo
Listen to The Lancet Neurology Cover
Listen to The Lancet Neurology Profile

Listen to The Lancet Neurology

English, Sciences, 1 season, 188 episodes, 1 day, 14 hours, 31 minutes
About
The Lancet Neurology is a monthly journal, renowned for the publication of high-quality peer-reviewed research, reviews, and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue, with occasional interviews with an author of a key article.
Episode Artwork

In conversation with... Marianne Chapleau and Gil Rabinovici

Marianne Chapleau and Gil Rabinovici join Senior Editor Sarah Passey to discuss their research on posterior cortical atrophy. The Article is published in the February issue of The Lancet Neurology.
1/23/202421 minutes, 45 seconds
Episode Artwork

In conversation with... Cecilia Åkerlund and David Nelson

Cecilia Åkerlund and David Nelson join The Lancet Neurology to discuss their research on clinical variables that might distinguish how the disease process progresses in people with traumatic brain injury. The Article is published in the January issue of The Lancet Neurology.
12/14/202318 minutes, 24 seconds
Episode Artwork

In conversation with... Rustam Al-Shahi Salman

Rustam Al-Shahi Salman joins Senior Editor Sarah Passey to discuss the COCROACH meta-analysis findings, published in the December issue of The Lancet Neurology, of the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage.
11/16/202324 minutes, 9 seconds
Episode Artwork

In conversation with... Njideka Okubadejo and Mie Rizig

Njideka Okubadejo and Mie Rizig join The Lancet Neurology to discuss their comprehensive genome-wide assessment in African and African admixed individuals with the aim of developing a better understanding of the genetic architecture of Parkinson's disease in these underserved populations.
10/24/202326 minutes, 34 seconds
Episode Artwork

In conversation with... Anthony Feinstein

Anthony Feinstein (University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada) discusses CogEx, a randomised trial of cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis. The Article is published in the October issue of The Lancet Neurology.
9/21/202314 minutes, 42 seconds
Episode Artwork

In conversation with... William Jagust

William Jagust (University of California in Berkeley, CA, USA) talks to Senior Editor Sarah Passey about the complex pathway between amyloid β and cognition, and implications for therapy for people with Alzheimer’s disease. His Personal View on this topic is published in the September issue of The Lancet Neurology.
8/17/202313 minutes, 36 seconds
Episode Artwork

In conversation with... Stephen Strittmatter

Stephen Strittmatter (Yale School of Medicine, CT, USA) discusses his first-in-human and randomised trial of a soluble Nogo-receptor-Fc decoy in patients with chronic cervical spinal cord injury. The Article is published in the August issue of The Lancet Neurology.
7/20/202314 minutes, 34 seconds
Episode Artwork

In conversation with... Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall

Benzi Kluger (University of Rochester Medical Center, Rochester, NY, USA), Claire Creutzfeldt (University of Washington, Seattle, WA, USA), and Malenna Sumrall (University of Colorado Anschutz Medical Campus, Aurora, CO, USA) join Jonathan Blott to discuss palliative care for individuals with neurological diseases, exploring the challenges and opportunities in enhancing the quality of life for those affected by neurological conditions. Their Review is published in the July issue of The Lancet Neurology.
6/23/202317 minutes, 20 seconds
Episode Artwork

In conversation with... Karen Duff and Connor Langworth-Green

Karen Duff and Connor Langworth-Green (University College London, London, UK) discuss tauopathies and the chronic effects of inflammation on this group of disorders. Their Personal View on this topic is published in the May issue of The Lancet Neurology.
4/13/202315 minutes, 20 seconds
Episode Artwork

In conversation with... Kerstin Hellwig

Kerstin Hellwig (Ruhr University Bochum, Bochum, Germany) discusses family planning considerations in multiple sclerosis. This Review is published in the April issue of The Lancet Neurology.
3/15/202314 minutes, 24 seconds
Episode Artwork

In conversation with... Geraldine Dawson

Geraldine Dawson (Duke University School of Medicine, NC, USA) discusses the latest advances and ongoing challenges in prediction of autism during infancy. This Review is published in the March issue of The Lancet Neurology.
2/15/202324 minutes, 34 seconds
Episode Artwork

In conversation with... Ellisiv Mathiesen

Ellisiv Mathiesen (The University of Tromsø – the Arctic University of Norway, Tromsø, Norway) discusses the findings of the TWIST trial, which investigated the use of tenecteplase for patients with wake-up stroke who were selected for treatment by non-contrast CT. This Fast-track Article is published in the February issue of The Lancet Neurology.
1/20/20238 minutes, 45 seconds
Episode Artwork

In conversation with... Beau Ances

Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology.
12/14/202211 minutes, 34 seconds
Episode Artwork

In conversation with... Axel Petzold

Axel Petzold (National Hospital for Neurology and Neurosurgery and Moorfields Eye Hospital, London, UK, and Amsterdam University Medical Center, Amsterdam, Netherlands) discusses a Position Paper, published in the December issue of The Lancet Neurology, which sets out new criteria for the diagnosis and classification of optic neuritis.
11/16/202220 minutes, 3 seconds
Episode Artwork

In conversation with... Maeike Zijlmans

Maeike Zijlmans (University Medical Center Utrecht, Utrecht, Netherlands) discusses recent research on tailoring of epilepsy surgery with biomarkers on intraoperative electrocorticography, and describes some of the challenges of this technique and what the future steps are for the field.
10/18/202214 minutes, 37 seconds
Episode Artwork

In conversation with... Jerome Siegel

Jerome Siegel (University of California, Los Angeles, CA, USA) discusses sleep research in hunter-gatherer populations and what we can learn from the sleep habits of various species; his Review is published in the October issue of The Lancet Neurology, which is the fourth paper in The Lancet’s Series on sleep and sleep disorders.
9/15/202243 minutes, 50 seconds
Episode Artwork

In conversation with... Laurent Servais and Dora Markati

Laurent Servais and Dora Markati (both from the University of Oxford, UK) discuss emerging therapies for Duchenne muscular dystrophy; their Review is published in the September issue of The Lancet Neurology.
8/11/20220
Episode Artwork

In conversation with... Andreas Charidimou

Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology.
7/14/202222 minutes, 58 seconds
Episode Artwork

In conversation with... Sarah Tabrizi and Cristina Sampaio

Sarah Tabrizi (UCL Queen Square Institute of Neurology, London, UK) and Cristina Sampaio (CHDI Foundation, Princeton, NJ, USA) discuss two papers on Huntington’s disease published in the July issue of The Lancet Neurology: a Position Paper outlining a new classification of the disease, called the Huntington’s Disease Integrated Staging System, and a Personal View on potential disease-modifying therapies.
6/16/202218 minutes, 52 seconds
Episode Artwork

In conversation with... Mark Hallett

Mark Hallett (National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA) discusses his Review, published in the June issue of The Lancet Neurology, on functional neurological disorder, and talks about new subtypes of this disorder, diagnostic challenges, and how education is important.
5/13/20228 minutes, 43 seconds
Episode Artwork

In conversation with... Eva Feldman

Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.
4/15/202222 minutes, 43 seconds
Episode Artwork

In conversation with... Estrella Morenas-Rodriguez and Christian Haass

Estrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, published in the April issue of The Lancet Neurology, on soluble TREM2 and its association with Alzheimer’s disease biomarkers and cognition.
4/6/202227 minutes, 15 seconds
Episode Artwork

In conversation with... John Collinge

John Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-protein monoclonal antibody, to patients with Creutzfeldt–Jakob disease; the report is published in the April issue of The Lancet Neurology.
3/17/202214 minutes, 45 seconds
Episode Artwork

In conversation with... Alexandra Durr

Alexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with spinocerebellar ataxia type 2, which is published in the March issue of The Lancet Neurology.
2/22/20227 minutes, 55 seconds
Episode Artwork

In conversation with... Giuseppe Citerio

Giuseppe Citerio (University of Milano-Bicocca, Milan, Italy) discusses the implications of a study from the CENTER-TBI project of the effect of frailty on 6-month outcome after traumatic brain injury, which is published in the February issue of The Lancet Neurology.
1/19/20229 minutes, 35 seconds
Episode Artwork

In conversation with... Alberto Costa

Alberto Costa (Case Western Reserve University, Cleveland, OH, USA) discusses his study on the use of memantine in adolescents and young adults with Down syndrome, which is published in the January issue of The Lancet Neurology.
12/21/202115 minutes, 14 seconds
Episode Artwork

In conversation with... Olivier Rascol

Olivier Rascol (Toulouse University, France) discusses the uses of amantadine in the treatment of patients with movement disorders, which are the focus of his Personal View in the December issue of The Lancet Neurology.
11/18/202128 minutes, 27 seconds
Episode Artwork

In conversation with... Antonio Uccelli

Antonio Uccelli (University of Genoa) discusses his research, published in the November issue of The Lancet Neurology, on the therapeutic use of mesenchymal stem cells for multiple sclerosis.
10/21/20210
Episode Artwork

In conversation with... Priya Palta

Priya Palta (Columbia University, New York) explains the importance of blood pressure control in the prevention of cognitive decline. Her Review, published in the October issue of The Lancet Neurology, provides an update of the mounting evidence that links hypertension with dementia risk.
9/15/20218 minutes, 23 seconds
Episode Artwork

In conversation with... Adam Boxer

Adam Boxer (University of California, San Francisco) discusses his research, published in the September issue of The Lancet Neurology, on diagnostic performance of tau biomarkers in neurodegenerative diseases.
8/18/202112 minutes, 13 seconds
Episode Artwork

In conversation with... Irene Cortese

Irene Cortese (National Institute of Neurological Disorders and Stroke) discusses the difficulties of designing clinical trials in progressive multifocal leukoencephalopathy.
7/22/20219 minutes, 58 seconds
Episode Artwork

In conversation with... Doug Turnbull

Doug Turnbull (University of Newcastle) discusses mitochondrial diseases in adults, which are reviewed in the July issue of The Lancet Neurology, and explains how important these diseases are for neurologists.
6/16/202120 minutes, 12 seconds
Episode Artwork

In conversation with... Geert Jan Biessels

Geert Jan Biessels (University Medical Centre Utrecht) discusses his research, published in The Lancet Neurology June issue, on using strategic infarct locations to predict post-stroke cognitive impairment.
5/19/20217 minutes, 59 seconds
Episode Artwork

In Conversation With... Henk-Jan Westeneng

Henk-Jan Westeneng discusses his new work on the causal effects of pre-symptomatic lifestyle on ALS.
4/22/20218 minutes, 36 seconds
Episode Artwork

In Conversation With... Anne MacGregor

Anne MacGregor discusses her recent Review of menstrual migraine, and explains why this disease needs greater recognition.
3/19/202112 minutes, 50 seconds
Episode Artwork

In Conversation With... Peter Rothwell

Peter Rothwell (Oxford University) discusses his new research, found in our new issue, on asymptomatic carotid stenosis and stroke.
2/18/20219 minutes, 25 seconds
Episode Artwork

Spinal cord injury and degenerative cervical myelopathy

Professor Michael Fehlings discusses the implications of his two papers in the Feb 2021 issue of The Lancet Neurology.
1/21/202119 minutes, 33 seconds
Episode Artwork

Genetic risk factors for sCJD

Emma Jones and Simon Mead discuss their article in The Lancet Neurology, identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease.
12/23/202023 minutes, 2 seconds
Episode Artwork

Prednisone in short-term prevention of cluster headache

Mark Obermann discusses his study examining the use of prednisone for the short-term prevention of cluster headache.
11/25/20209 minutes, 9 seconds
Episode Artwork

PET imaging of inflammation in neurological and psychiatric disorders

Robert Innis discusses his work on measuring neuroinflammation using PET imaging.
10/21/20200
Episode Artwork

Neurological associations of COVID-19

Tom Solomon discusses his Rapid Review on neurologically-associated COVID-19 problems, in The Lancet Neurology.
9/4/202011 minutes, 23 seconds
Episode Artwork

Advances in understanding of Rett syndrome

Huda Zoghbi discusses the prospects for future therapies in Rett syndrome.
7/31/202020 minutes, 44 seconds
Episode Artwork

Management of Parkinson's disease

Bas Bloem chats about his new research into a network model for reshaping chronic neurological care for patients with Parkinson's disease.
6/17/202010 minutes, 43 seconds
Episode Artwork

Optimal time to treat Huntington's Disease

Sarah Tabrizi discusses her new research into analysing the early onset of Huntington's Disease.
5/26/202012 minutes, 55 seconds
Episode Artwork

Evidence-based support for autistic people across the lifespan

Meng-Chuan Lai discusses the current evidence base for supporting autistic people.
4/28/202021 minutes, 14 seconds
Episode Artwork

Oral immunomodulating therapies in relapsing MS

Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.
3/19/20200
Episode Artwork

The global burden of neurological conditions

Andrea Winkler discusses the global burden caused by stroke, epilepsy, dementia, and neuroinfections, and what low- and middle-income countries can do.
11/6/201937 minutes, 11 seconds
Episode Artwork

Blood pressure and brain structure

Jonathan Schott discusses the associations between blood pressure across adulthood and late-life brain structure and pathology.
9/13/201910 minutes, 10 seconds
Episode Artwork

Fetal alcohol spectrum disorder

Jeffrey Wozniak talks about his Review in The Lancet Neurology, on clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.
9/12/201910 minutes, 42 seconds
Episode Artwork

Stroke genetics

Martin Dichgans discusses advancements in the field of stroke genetics.
5/21/201916 minutes, 37 seconds
Episode Artwork

Next-generation sequencing and clinical neurology

Brent Fogel talks to The Lancet Neurology about his work on large-scale genomic analysis.
4/12/20197 minutes, 46 seconds
Episode Artwork

Role of astroglia in Alzheimer's disease

Amaia Arranz and Bart De Strooper discuss their Review on the role of astroglia in Alzheimer's disease.
3/14/201915 minutes, 4 seconds
Episode Artwork

Sleep disturbance and dementia risk

Michael Irwin (University of California, Los Angeles, USA) discusses a Review concerning potential links of sleep disturbance and possible increased risk of Alzheimer's disease dementia.
2/13/201911 minutes, 11 seconds
Episode Artwork

Frailty and Alzheimer's

Lindsay Wallace and Kenneth Rockwood join The Lancet Neurology to talk about their work on the association between frailty and the onset of Alzheimer's disease.
1/22/201912 minutes, 13 seconds
Episode Artwork

Stroke–heart syndrome

In the latest podcast from The Lancet Neurology, Jan Scheitz discusses the development of stroke–heart syndrome.
11/22/201810 minutes, 40 seconds
Episode Artwork

Epileptic seizures

Mark Cook and Phillippa Karoly join The Lancet Neurology to discuss their retrospective study of cyclical patterns in epileptic seizures.
10/16/201811 minutes, 42 seconds
Episode Artwork

Cerebral white matter demyelination in multiple sclerosis

Bruce Trapp and Daniel Ontaneda discuss their retrospective study investigating cortical neuronal loss and cerebral white-matter demyelination in mulitple sclerosis.
9/18/201815 minutes, 30 seconds
Episode Artwork

Autoimmune encephalitis after herpes simplex encephalitis

Josep Dalmau joins The Lancet Neurology to discuss recognition and outcomes of autoimmune encephalitis after herpes simplex encephalitis.
7/24/201810 minutes, 29 seconds
Episode Artwork

Network imaging biomarkers

David Eidelberg and Katharina Schindelbeck join The Lancet Neurology to explain their new review of the applications of network imaging biomarkers in Parkinson's disease.
6/16/201820 minutes, 21 seconds
Episode Artwork

Progressive multifocal leukoencephalopathy

Eugene Major and David Clifford join The Lancet Neurology to discuss their review of pathogenesis and treatments for progressive multifocal leukoencephalopathy.
5/4/201819 minutes, 45 seconds
Episode Artwork

Antiepileptic drugs and risk of congenital malformation

Torbjörn Tomson discusses the issue of antiepileptic drugs during pregnancy and the risk of major congenital malformations.
4/30/20187 minutes, 57 seconds
Episode Artwork

Seizure detection and reporting in epilepsy: The Lancet Neurology: February 13, 2018

Christian Elger discusses the diagnostic challenges in epilepsy with the detection and reporting of seizures.
2/14/20186 minutes, 3 seconds
Episode Artwork

MS McDonald criteria revisions: The Lancet Neurology: February 2018

Jeffrey Cohen joins us to talk about the process of updating and revising the McDonald criteria for diagnosis of MS.
1/19/20189 minutes, 1 second
Episode Artwork

GWAS on dementia with Lewy bodies: The Lancet Neurology: January, 2018

Jose Bras discusses his study of the genetic architecture of dementia with Lewy bodies.
12/16/20176 minutes, 18 seconds
Episode Artwork

Traumatic Brain Injury: The Lancet Neurology: November 7, 2017

Andrew Maas and David Menon, lead authors, discuss The Lancet Neurology Commission on traumatic brain injury and outline the worldwide burden.
11/7/201737 minutes, 30 seconds
Episode Artwork

TDP-43 and Alzheimer's disease: The Lancet Neurology: November 2017

Keith Josephs talks about considering TDP-43 as a potential factor related to increased rates of hippocampal atrophy in patients with Alzheimer's disease.
10/11/20179 minutes, 9 seconds
Episode Artwork

Biomarkers in stroke recovery: The Lancet Neurology: October 2017

Cathy Stinear discusses her review of biomarkers that might predict motor recovery after stroke.
9/13/20177 minutes
Episode Artwork

Genetic variants and Huntington's: The Lancet Neurology: September 2017

Lesley Jones and Sarah Tabrizi talk about their work on the identification of genetic markers associated with the progression of Huntington's disease.
8/9/201718 minutes, 40 seconds
Episode Artwork

Simvastatin and MS: The Lancet Neurology: August 2017

Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
7/12/20174 minutes, 50 seconds
Episode Artwork

Progressive supranuclear palsy: The Lancet Neurology: July 2017

Adam Boxer offers an overview of the latest on diagnosis and treatment for progressive supranuclear palsy.
6/14/201724 minutes, 27 seconds
Episode Artwork

Neurological consequences of obesity: The Lancet Neurology: May 9, 2017

Eva Feldman discusses the neurological consequences of obesity.
5/9/20179 minutes, 53 seconds
Episode Artwork

Neurodegenerative disease: The Lancet Neurology: February 23, 2017

Marc Diamond discusses his Personal View on the prion model for progression and diversity of neurodegenerative diseases.
2/24/201721 minutes, 10 seconds
Episode Artwork

Autosomal dominant familial Alzheimer's disease: The Lancet Neurology: 21 October 2016

Randall Bateman and Nick Fox discuss what they've learned from their papers on Alzheimer's disease.
10/22/201621 minutes, 15 seconds
Episode Artwork

Ventilation for ALS patients: The Lancet Neurology: November 2016

Professor Thomas Similowski discusses his surprising study on the effectiveness of non-invasive ventilation for patients with amyotrophic lateral sclerosis.
10/12/20169 minutes, 40 seconds
Episode Artwork

Sleep disorders in children: The Lancet Neurology: September 12, 2016

Dr. Kiran Maski discusses insomnia, parasomnia, and narcolepsy in children.
9/13/20166 minutes, 8 seconds
Episode Artwork

Non-immersive Virtual Reality Exercise in Stroke Rehabilitation

Dr. Gustavo Saposnik discusses the efficacy of non-immersive virtual reality exercise in the treatment of stroke.
7/1/20167 minutes, 57 seconds
Episode Artwork

Global burden of stroke: The Lancet Neurology: June 22, 2016

Professor Valery Feigin discusses an Article on the global burden of stroke and risk factors from 1990–2013.
6/24/201611 minutes, 5 seconds
Episode Artwork

Stakeholder cooperation in orphan drug development: The Lancet Neurology: June 6, 2016

Annemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases.
6/7/201611 minutes, 20 seconds
Episode Artwork

The Lancet Neurology Conference: Preclinical neurodegenerative disease: towards prevention and early diagnosis

Richard Lane interviews John Hardy, Jonathan Rohrer and Sarah Tabrizi, who are members of the Scientific Committee.
2/24/201612 minutes, 46 seconds
Episode Artwork

World encephalitis day: The Lancet Neurology: February 22, 2016

Francesc Graus and Josep Dalmau discuss new criteria for a clinical approach for the diagnosis of autoimmune encephalitis.
2/22/201616 minutes, 21 seconds
Episode Artwork

Cerebral cavernous malformations: The Lancet Neurology: February 2016

Rustam Salman discusses how the assessment of cerebral cavernous malformations can help identify people at risk of subsequent brain haemorrhage.
1/12/201611 minutes, 44 seconds
Episode Artwork

ParkinsonNet: The Lancet Neurology: January 8, 2016

Bas Bloem talks about ParkinsonNet, a healthcare model that supports a multidisciplinary network for people with Parkinson’s disease.
1/9/201621 minutes, 21 seconds
Episode Artwork

Biomarkers and dementia: The Lancet Neurology: Jan 2016

Clifford Jack from the Mayo Clinic discusses a research article which investigates the role of biomarkers to help identify preclinical dementia.
12/8/201518 minutes, 33 seconds
Episode Artwork

Diaphragm pacing for ALS: The Lancet Neurology: July 31, 2015

Chris McDermott and Richard Lane discuss the DiPALS study, investigating the effect of diaphragm pacing in addition to non-invasive ventilation in patients with ALS.
7/31/201514 minutes, 45 seconds
Episode Artwork

Endovascular stent thrombectomy: The Lancet Neurology: July 13, 2015

Bruce Campbell discusses the remarkable benefits of endovascular treatment for ischaemic stroke.
7/14/20159 minutes, 38 seconds
Episode Artwork

Lower urinary tract dysfunction: The Lancet Neurology: June 16, 2015

Jalesh Panicker discusses lower urinary tract dysfunction, a common problem in people with neurological disorders.
6/16/201523 minutes, 46 seconds
Episode Artwork

Status epilepticus: The Lancet Neurology: June 1, 2015

Daniel Lowenstein discusses research into status epilepticus.
6/1/20159 minutes, 43 seconds
Episode Artwork

Apathy in Parkinson's disease: The Lancet Neurology: April 21, 2015

Paul Krack discusses apathy in Parkinson's disease.
4/21/201516 minutes, 20 seconds
Episode Artwork

Neuroinflammation in Alzheimer’s disease: The Lancet Neurology: March 16, 2015

In an interview Michael Heneka considers the contribution of neuroinflammatory mechanisms to Alzheimer’s disease pathogenesis.
3/16/201513 minutes, 12 seconds
Episode Artwork

The Lancet Neurology: February 16, 2015

Steven Goodrick talks to Jonathan Rohrer about the latest research in C9orf72 expansions.
2/17/201510 minutes, 6 seconds
Episode Artwork

The Lancet Neurology: January 16, 2015

Alan Thompson and Steven Goodrick discuss a new three-part Series on progressive MS. 
1/17/201514 minutes, 41 seconds
Episode Artwork

The Lancet Neurology: December 8, 2014

Gabrielle deVeber discusses a Review on childhood stroke.
12/9/201410 minutes, 55 seconds
Episode Artwork

The Lancet Neurology: November 19, 2014

Jonathan Smith discusses how assessment of pain in elderly adults with dementia differs from that in healthy elderly adults.
11/19/20148 minutes, 22 seconds
Episode Artwork

The Lancet Neurology: October 13, 2014

Professor Ammar Al-Chalabi discusses a population based modelling study of the development of amyotrophic lateral sclerosis.
10/13/20144 minutes, 52 seconds
Episode Artwork

The Lancet Neurology: September 15, 2014

Steven Galetta discusses his Review on how tests of visual function can be useful in the assessment of minor head injury and TBI.
9/15/20146 minutes, 27 seconds
Episode Artwork

The Lancet Neurology: July 14, 2014

Sir Graham Teasdale reflects on the Glasgow COMA scale for brain injury, 40 years after it was published in The Lancet.
7/14/201410 minutes, 44 seconds
Episode Artwork

The Lancet Neurology: June 16, 2014

John Hardy discusses a genome-wide association study on frontotemporal dementia and its subtypes.
6/16/20147 minutes, 10 seconds
Episode Artwork

The Lancet Neurology: May 07, 2014

David Bennett discusses painful and painless channelopathies.
5/7/201418 minutes, 6 seconds
Episode Artwork

The Lancet Neurology: April 03, 2014

Dr. David McDonagh and Professor Mark Newman discuss the neurological complications of cardiac surgery.
4/3/201414 minutes, 41 seconds
Episode Artwork

The Lancet Neurology: February 14, 2014

Craig Anderson discusses findings from a study about the effects of blood pressure variability on outcomes for patients with intracerebral haemorrhage.
2/14/20147 minutes, 22 seconds
Episode Artwork

The Lancet Neurology: January 20, 2014

Henrik Hagberg discusses the role of mitochondria in CNS development and in the injury responses of the developing brain.
1/20/201416 minutes, 8 seconds
Episode Artwork

The Lancet Neurology: December 02, 2013

Finbar O'Callaghan from the Institute for Child Health, London, discusses new research about the incidence and risk factors for childhood stroke.
12/2/20139 minutes, 54 seconds
Episode Artwork

The Lancet Neurology: November 11, 2013

In an extended interview, Nicholas Abend from the Children's Hospital of Philadelphia discusses a Review on electrographic seizures and status epilepticus in critically ill children and neonates with encephalopathy.
11/12/201336 minutes, 59 seconds
Episode Artwork

The Lancet Neurology: September 17, 2013

Hugh Marcus from the University of Cambridge discussing a Review on stroke and TIA in the posterior territory.
9/17/20136 minutes, 58 seconds
Episode Artwork

The Lancet Neurology: August 08, 2013

Francisco Javier Carod-Artal discusses a Review concerning the neurological complications of dengue virus infection.
8/8/201317 minutes, 9 seconds
Episode Artwork

The Lancet Neurology: July 11, 2013

Paul Hagerman discusses a Review which highlights the latest clinical and molecular understanding of the FMR1 mutation and FXTAS.
7/11/201310 minutes, 27 seconds
Episode Artwork

The Lancet Neurology: June 10, 2013

Sarah Tabrizi discusses the latest findings of the TRACK HD study concerning Huntington's disease.
6/10/201313 minutes, 9 seconds
Episode Artwork

The Lancet Neurology: May 22, 2013

Klaus Fassbender discusses a Review about streamlining pre-hospital management of stroke.
5/22/20139 minutes, 56 seconds
Episode Artwork

The Lancet Neurology: April 17, 2013

Joanna Wardlaw discusses the poorly understood condition of cerebral small vessel disease.
4/17/201314 minutes, 50 seconds
Episode Artwork

The Lancet Neurology: March 18, 2013

Jim Barkovich from UCSF discusses a Review about midbrain and hindbrain disorders.
3/18/201310 minutes, 10 seconds
Episode Artwork

The Lancet Neurology: February 13, 2013

Kim Meador explains the effects of fetal exposure to anti-epileptic drugs, plus other highlights from the March issue.
2/13/201314 minutes, 2 seconds
Episode Artwork

The Lancet Neurology: January 16, 2013

Josep Dalmau describes the clinical and pathological features of anti-NMDA receptor encephalitis.
1/16/201312 minutes, 59 seconds
Episode Artwork

The Lancet Neurology: December 07, 2012

Roger Barker discusses fetal dopaminergic transplantation as a therapeutic option for Parkinson's disease.
12/7/201211 minutes, 41 seconds
Episode Artwork

The Lancet Neurology: November 15, 2012

Eric Reiman discusses a research article, where biomarker changes are assessed in early onset Alzheimer's disease.
11/16/201212 minutes, 6 seconds
Episode Artwork

The Lancet Neurology: October 29, 2012

Marjo van der Knaap discusses megalencephalic leukoencephalopathy with subcortical cysts.
10/29/201212 minutes, 47 seconds
Episode Artwork

The Lancet Neurology: September 18, 2012

Bjarne Udd discusses the myotonic dystrophies.
9/18/201210 minutes, 52 seconds
Episode Artwork

The Lancet Neurology: August 13, 2012

Frank Gilliam discusses the adverse effects of anti-epileptic drugs.
8/13/201218 minutes, 42 seconds
Episode Artwork

The Lancet Neurology: July 13, 2012

Highlights from the August issue, and Dag Aarsland discusses dementia in patients with Parkinson's disease.
7/13/201211 minutes, 17 seconds
Episode Artwork

The Lancet Neurology: June 13, 2012

Justin McArthur discusses CNS opportunistic infections within the context of HIV.
6/13/201214 minutes, 17 seconds
Episode Artwork

The Lancet Neurology: May 16, 2012

Brian Callaghan discusses a Review about diabetic neuropathy.
5/16/20128 minutes, 15 seconds
Episode Artwork

The Lancet Neurology: April 17, 2012

Hudson Freeze discusses a Review about the neurology of inherited glycosilation disorders.
4/17/201212 minutes, 46 seconds
Episode Artwork

The Lancet Neurology: March 19, 2012

Peter Langhorne discusses the potential of specialist stroke units in low and middle-income settings.
3/19/201215 minutes, 16 seconds
Episode Artwork

The Lancet Neurology: February 16, 2012

Kailash P Bhatia discusses a Review on the epidemiology, clinical features, diagnosis, and treatment of functional movement disorders.
2/16/201211 minutes, 46 seconds
Episode Artwork

The Lancet Neurology: January 18, 2012

Discussion of a Review about posterior cortical atrophy, and other issue highlights.
1/18/201211 minutes, 25 seconds
Episode Artwork

The Lancet Neurology: December 12, 2011

Discussion of the links between nutrition and stroke risk.
12/12/201120 minutes, 9 seconds
Episode Artwork

The Lancet Neurology: November 11, 2011

Brenda Banwell discusses the potential of MRI screening after a first demyelinating event as a future predictor of MS in children.
11/11/201113 minutes, 49 seconds
Episode Artwork

The Lancet Neurology: October 17, 2011

Chris Polman discusses a Rapid Review of new oral therapies for patients with multiple sclerosis.
10/17/201116 minutes, 3 seconds
Episode Artwork

The Lancet Neurology: September 19, 2011

Ashfaq Shuaib talks about collateral blood flow in the brain as a potential therapeutic target for patients with acute ischaemic.
9/19/201110 minutes, 56 seconds
Episode Artwork

The Lancet Neurology: August 15, 2011

How Alzheimer's disease prevalence could be associated with modifiable risk factors.
8/15/201115 minutes, 19 seconds
Episode Artwork

The Lancet Neurology: July 18, 2011

August issue highlights, including discussion of a genetic association study concerning intracerebral haemorrhage.
7/18/201110 minutes
Episode Artwork

The Lancet Neurology: June 15, 2011

July issue highlights, including discussion of the EURAP Registry concerning a possible association between anti-epileptic drugs and congenital birth defects.
6/15/201110 minutes, 14 seconds
Episode Artwork

The Lancet Neurology: May 18, 2011

Bas Bloem discusses a review in the June issue about postural abnormalities associated with Parkinson's disease.
5/18/201112 minutes, 38 seconds
Episode Artwork

The Lancet Neurology: April 13, 2011

Discussion of new data from the ADAGIO trial for the treatment of Parkinson's disease, and a Canadian cohort study assessing risk factors for multiple sclerosis in children.
4/13/20119 minutes, 46 seconds
Episode Artwork

The Lancet Neurology: March 23, 2011

Highlights from the April issue with a focus on aneurysmal subarachnoid haemorrhage.
3/23/20118 minutes, 48 seconds
Episode Artwork

The Lancet Neurology: February 21, 2011

Highlights from the March issue with a focus on neurodegenerative disease.
2/21/20119 minutes, 50 seconds
Episode Artwork

The Lancet Neurology: January 19, 2011

Prozac and motor function after stroke, and the effect of rapid hypothermia after brain injury.
1/19/20118 minutes, 41 seconds
Episode Artwork

The Lancet Neurology: December 13, 2010

January highlights, including discussion of research from the TRACK-HD study for Huntington's disease.
12/13/20106 minutes, 29 seconds
Episode Artwork

The Lancet Neurology: November 16, 2010

Discussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.
11/16/201010 minutes, 42 seconds
Episode Artwork

The Lancet Neurology: September 20, 2010

October issue highlights, including cilostazol compared with aspirin for secondary stroke prevention.
9/20/20109 minutes, 40 seconds
Episode Artwork

The Lancet Neurology: August 16, 2010

September issue highlights, including the effects of a longer treatment window with alteplase after stroke, and discussion of a Review about ataxia.
8/16/20107 minutes, 35 seconds
Episode Artwork

The Lancet Neurology: July 19, 2010

The use of blood-pressure-lowering therapy after stroke, limbic encephalitis, and discussion of Huntington's disease prevalence.
7/19/201015 minutes, 49 seconds
Episode Artwork

The Lancet Neurology: June 17, 2010

July highlights, including ultrasound to detect asymptomatic carotid stenosis in stroke prevention.
6/17/20109 minutes, 13 seconds
Episode Artwork

The Lancet Neurology: May 19, 2010

June issue highlights, including discussion of depression and Parkinson's disease.
5/19/20109 minutes, 16 seconds
Episode Artwork

The Lancet Neurology: April 21, 2010

Lithium therapy and ALS, and stroke associated with Chaga's disease.
4/21/201011 minutes, 30 seconds
Episode Artwork

The Lancet Neurology: March 15, 2010

Discussion of April issue highlights, including the International Carotid Stenting study.
3/15/20107 minutes, 17 seconds
Episode Artwork

The Lancet Neurology: February 18, 2010

Discussion of concerns over generic substitution of antiepileptic drugs.
2/18/201010 minutes, 33 seconds
Episode Artwork

The Lancet Neurology: January 18, 2010

Alison Rowan discusses issue highlights, including PET imaging for the diagnosis of Parkinson's disease.
1/18/20109 minutes, 22 seconds
Episode Artwork

The Lancet Neurology: December 14, 2009

Kate Bushby discusses two reviews on Duchenne Muscular Dystrophy.
12/14/200912 minutes, 52 seconds
Episode Artwork

The Lancet Neurology: October 12, 2009

Discussion of the BENEFIT study for MS and the role of elderly people in neurological research.
10/12/20097 minutes, 38 seconds
Episode Artwork

The Lancet Neurology: September 08, 2009

Discussion of the CAVATAS trial for carotid stenosis.
9/8/20097 minutes, 24 seconds
Episode Artwork

The Lancet Neurology: August 19, 2009

Helen Frankish discusses articles about Huntington's disease and stroke.
8/19/200912 minutes, 54 seconds
Episode Artwork

The Lancet Neurology: July 15, 2009

Discussion of deep-brain stimulation for cerebral palsy, and rehabilitation interventions for motor recovery after stroke.
7/15/20094 minutes, 54 seconds
Episode Artwork

The Lancet Neurology: June 15, 2009

Alison Rowan discusses epilepsy services in the UK, and a review about CADASIL.
6/15/20096 minutes, 12 seconds
Episode Artwork

The Lancet Neurology: May 12, 2009

Helen Frankish discusses research on childhood stroke, and add-on drug therapy for MS.
5/12/20099 minutes, 30 seconds
Episode Artwork

The Lancet Neurology: April 15, 2009

Elena Becker-Barroso discusses the ISAT study follow-up, and paracetamol use in acute stroke.
4/15/20096 minutes, 39 seconds
Episode Artwork

The Lancet Neurology: March 16, 2009

Helen Frankish discusses the global incidence of stroke, and a research article assessing the malaria drug quinacrine for the treatment of prion disease.
3/16/20098 minutes, 48 seconds
Episode Artwork

The Lancet Neurology: February 16, 2009

Helen Frankish discusses articles on stroke prevention after TIA, and the potential of stem-cell therapy for the treatment of multiple sclerosis.
2/16/20097 minutes, 41 seconds
Episode Artwork

The Lancet Neurology: January 19, 2009

Helen Frankish discusses antipsychotics and Alzheimer's disease, and desmoteplase for ischaemic stroke.
1/19/200910 minutes
Episode Artwork

The Lancet Neurology: December 08, 2008

Helen Frankish discusses articles about galantamine for severe Alzheimer's disease, and a genome-wide association study about CJD.
12/8/20089 minutes, 18 seconds
Episode Artwork

The Lancet Neurology: November 10, 2008

Helen Frankish discusses articles on NMDA-receptor encephalitis, perilesional brain oedema, and looks ahead to the TLN stroke conference in Beijing.
11/10/20087 minutes, 58 seconds
Episode Artwork

The Lancet Neurology: October 13, 2008

In this month's Lancet Neurology Podcast, Editor Helen Frankish discusses two research articles: one on the treatment of hemicrania continua, and another on perception of pain in a minimally conscious state. Also discussed is a review on sudden unexpected death in epilepsy.
10/13/20088 minutes, 28 seconds
Episode Artwork

The Lancet Neurology: September 15, 2008

Helen Frankish discusses highlights from the October issue, including follow-up results for trials comparing carotid stenting with endarterectomy in patients with stenosis; and the PRoFESS study comparing drug combinations to reduce the severity of recurrent ischaemic stroke.
9/15/20086 minutes, 32 seconds
Episode Artwork

The Lancet Neurology: August 11, 2008

Elena Becker-Barroso discusses highlights from the September issue, including the potential of PB2 to slow the development of amyloid beta in patients with Alzheimer's, and how telemedicine could improve stroke treatment.
8/11/20088 minutes, 1 second
Episode Artwork

The Lancet Neurology: July 14, 2008

Helen Frankish discusses biomarkers for indications of dementia, and other highlights from the August issue.
7/14/20088 minutes, 9 seconds
Episode Artwork

The Lancet Neurology: June 16, 2008

The International LRRK2 Consortium, which includes investigators in 21 centres, has collected data from almost 20000 patients with Parkinson's disease carrying mutations in the LRRK2 gene. The Lancet Neurology editor Elena Becker-Barroso and Daniel Healy, the corresponding author on their first report, summarises the findings and their implications in clinical practice in a podcast.
6/16/200816 minutes, 4 seconds
Episode Artwork

The Lancet Neurology: May 19, 2008

Editor Helen Frankish discusses highlights from the June issue: a randomised trial showing the efficacy of a ketogenic diet to protect against childhood epilepsy; and a trial with phase II results for the Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease.
5/19/20086 minutes, 38 seconds
Episode Artwork

The Lancet Neurology: April 18, 2008

Editor Helen Frankish discusses highlights from the May issue: results from the INTERACT trial showing how intensive blood pressure lowering could be beneficial for people who have had intra cranial haemorrhage; also discussion of a genetic study identifying a gene mutation involved in amyloid lateral sclerosis, and a review of stroke in children.
4/18/20087 minutes, 5 seconds
Episode Artwork

The Lancet Neurology: March 14, 2008

Editor Helen Frankish discusses highlights from the April issue: including the EPITHET study of alteplase treatment 3-6 hours after a stroke, and donepezil treatment in patients with CADASIL, a genetic form of vascular dementia.
3/14/20085 minutes, 6 seconds
Episode Artwork

The Lancet Neurology: February 18, 2008

Editor Helen Frankish discusses highlights from the March issue: including research Articles about a genetic clue to the cause of dystonia, a neurological disorder relating to Parkinson's disease; and a study identifying older age (68 years) as a risk factor for stroke among people given stenting rather than Endarterectomy to unblock the carotid artery.
2/18/20085 minutes, 27 seconds
Episode Artwork

The Lancet Neurology: January 22, 2008

Imaging of amyloid β in Alzheimer's disease with a novel PET tracer Amyloid β (Aβ) deposits can be imaged by PET, but most Aβ PET ligands are not suitable for clinical diagnosis of Alzheimer's disease (AD). To test the effectiveness of a new Aβ PET ligand, 18F-BAY94-9172, Christopher Rowe and colleagues compared its binding with Aβ deposition in patients with AD, individuals with frontotemporal lobar degeneration, and healthy controls. Helen Frankish discusses the study in this month's podcast, and highlights the editorial concerning the possible tagging of individuals with AD.
1/22/20086 minutes, 38 seconds
Episode Artwork

The Lancet Neurology: December 17, 2007

Epilepsy in children encompasses several syndromes that have different prognoses but are all characterised by a predisposition to recurrent seizures; therefore, treatment has to be tailored to the individual. Any treatment regimen for children with epilepsies should have rational goals, take into account the additional morbidities that are commonly found in these patients.
12/17/20076 minutes, 36 seconds
Episode Artwork

The Lancet Neurology: November 21, 2007

Editor Helen Frankish discusses highlights from the December issue: original research investigating the efficacy of minocycline for the treatment of amyotrophic lateral sclerosis (ALS); a randomised trial assessing the effect and treatment duration of topiramate for the prevention of migraine; and a brief discussion of a review about medulloblastoma in children.
11/21/20077 minutes, 27 seconds
Episode Artwork

The Lancet Neurology: October 22, 2007

Editor Helen Frankish discusses highlights from the November issue: two Articles looking at the early treatment of minor strokes or transient ischaemic attacks and the risk of stroke, an Editorial calling for more funding for headache research, and a large multinational study identifying genetic variants that influence the development of epilepsy.
10/22/20075 minutes, 34 seconds
Episode Artwork

The Lancet Neurology: September 27, 2007

Editor Helen Frankish discusses this month's leading edge editorial: the unsuccessful appeal against the UK National Institute for Health and Clinical Excellence (NICE) after its recent decision to not make dementia therapies widely available in the UK on grounds of cost-effectiveness
9/27/20074 minutes, 50 seconds
Episode Artwork

The Lancet Neurology: August 13, 2007

Editor Helen Frankish discusses highlights from the September issue: an association between Epstein-Barr virus and acquisition of multiple sclerosis in children; and current opportunities for the development of anti-epileptic drugs. Epilepsy and HIV are also discussed in this month's leading edge editorial.
8/13/20075 minutes, 40 seconds
Episode Artwork

The Lancet Neurology: July 13, 2007

Editor Helen Frankish discusses two topics from the August issue: a research article suggesting people with epilepsy are three times more likely than the general population to commit suicide; and she interviews the author of a position paper about a new research framework for the diagnosis of Alzheimer's disease.
7/13/20079 minutes, 9 seconds
Episode Artwork

The Lancet Neurology: June 20, 2007

In this month's Lancet Neurology podcast Helen Frankish discusses a research article concerning numerous factors which determine the risk of recurrent venous thromboembolism after cerebral venous thromboembolism in children. Also discussed is the Leading Edge editorial calling for a more modern approach to stroke services in the UK, and the review about silent infarcts, which could be a useful way of detecting neurological disease before symptoms develop.
6/20/20075 minutes, 41 seconds
Episode Artwork

The Lancet Neurology: May 16, 2007

Editor Helen Frankish discusses highlights from the June issue: research from the University of Oxford about the incidence of haemorragic stroke; while incidence has decreased in younger age groups over the past two decades, inclusion of data from people aged over 75 years shows how overall incidence has remained the same, underlining the need for the inclusion of older people in stroke research. Also discussed is the comprehensive review on migraine and this month's editorial about stem-cell research in the USA.
5/16/20076 minutes, 12 seconds
Episode Artwork

The Lancet Neurology: April 24, 2007

Editor Helen Frankish discusses highlights from the May issue. The GIST trial concerning blood glucose levels after stroke, despite being stopped early, has implications for future research in this area.
4/24/20075 minutes, 40 seconds
Episode Artwork

The Lancet Neurology: March 19, 2007

Editor Helen Frankish discusses the April issue, including promising research on occipital-nerve stimulation for cluster headache, and a new method to aid the diagnosis of Lewy body dementia.
3/19/20074 minutes, 42 seconds
Episode Artwork

The Lancet Neurology: February 26, 2007

Editor Helen Frankish discusses highlights from the March issue: a pooled analysis of three randomised trials which shows how decompression surgery soon after stroke onset can reduce mortality.
2/26/20079 minutes, 56 seconds
Episode Artwork

The Lancet Neurology: January 18, 2007

This month's podcast discusses the themed stroke issue coinciding with the International Stroke Conference taking place in San Francisco in early February. Also discussed is the first of a series of articles on stroke in developing countries.
1/18/20075 minutes, 12 seconds
Episode Artwork

The Lancet Neurology: December 11, 2006

Highlights from the January issue of The Lancet Neurology, includes a research article on epilepsy in sub-Saharan Africa and the Leading Edge urging WHO to prioritise neurological diseases.
12/11/20064 minutes, 58 seconds
Episode Artwork

The Lancet Neurology: November 14, 2006

December's Listen to The Lancet Neurology highlights the negative outcome of a trial of the drug TCH346 as a neuroprotective agent for Parkinson's disease, a Review about meningiomas, and depression among people with neurological disease.
11/14/20065 minutes, 12 seconds
Episode Artwork

The Lancet Neurology: October 17, 2006

Editor Helen Frankish discusses the highlights from the November issue, which this month has a focus on Parkinson's disease.
10/17/20064 minutes, 26 seconds
Episode Artwork

The Lancet Neurology: September 18, 2006

October's TLN podcast includes a discussion of a paper on epilepsy in China, and a Forum article on possible infectious causes of multiple sclerosis.
9/18/20066 minutes, 6 seconds
Episode Artwork

In conversation with... Andrew Cole

Andrew Cole (Massachusetts General Hospital Epilepsy Service, Boston, MA, USA) talks to Senior Editor Sarah Passey about the complexities underlying epilepsy in people with glioblastoma. His Review on this topic is published in the June issue of The Lancet Neurology.
1/1/118 minutes, 38 seconds
Episode Artwork

Thrombectomy for ischaemic stroke

Bruce Campbell joins The Lancet Neurology to discuss his systematic review of the HERMES collaboration.
1/1/18 minutes, 49 seconds